Last --
Change Today 0.00 / 0.00%
Volume 0.0
4502 On Other Exchanges
Symbol
Exchange
4502 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Naohisa Takeda

AgeTotal Calculated CompensationThis person is connected to 18 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Mr. Naohisa Takeda has been a Corporate Auditor at Takeda Pharmaceutical Company Limited, since 2008. Mr. Takeda served as General Manager of Department of Europe & Asia at Takeda Pharmaceutical Co. Ltd. since 2003 and served as its General Manager of Department of Europe, Pharmaceutical International Division since 2000. Mr. Takeda joined Takeda Pharmaceutical Co. Ltd in 1972 and served as its Corporate Officer since 2005; and General Manager of Overseas Business Planning ...

Read Full Background

Corporate Headquarters*

1-1, Doshomachi 4-chome
Osaka, -- 540-8645

Japan

Phone: 81 6 6204 2111
Fax: 81 6 6204 2880

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4502:JP ¥5,059.00 JPY +58.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
$930.0K
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Haruo Naito Chief Executive Officer, Representative Corporate Officer and Director
Eisai Co., Ltd.
--
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.